Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

iodine I 124 18B10(10L)

A radioconjugate composed of an antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform of claudin-18), and conjugated with the radioisotope iodine I 124, that can potentially be used as an imaging agent for positron emission tomography (PET)/computed tomography (CT). Upon administration, the antibody moiety of iodine I 124 18B10(10L) selectively targets and binds to CLDN18.2. The CLDN18.2-expressing tumor cells can then be visualized using PET/CT. CLDN18.2, a tight junction protein and stomach-specific isoform of claudin-18, is expressed on a variety of tumor cells. Its expression in healthy tissues is strictly confined to short-lived differentiated epithelial cells of the gastric mucosa.
Synonym:[124I]-18B10(10L)
124I-18B10(10L)
Search NCI's Drug Dictionary